M. Denis

Toward the biologic release of human insulin from skeletal muscle.

R. Bartlett, C. Ricordi, R. Alejandro, 1997, Transplantation proceedings.

Anti-IL2 receptor monoclonal antibody (33B3.1) in prophylaxis of early kidney rejection in humans: a randomized trial versus rabbit antithymocyte globulin.

M. Giral, J. Soulillou, D. Cantarovich, 1989, Transplantation proceedings.

Real-time sequence-specific primer polymerase chain reaction amplification of HLA class II alleles: a novel approach to analyze microchimerism.

C. Ricordi, A. Pugliese, D. Klein, 2002, Transplantation.

Soluble interleukin 2 receptor (Tac chain) is not a reliable marker in kidney transplant recipient monitoring

J. Trochu, M. Giral, J. Soulillou, 1992, Transplant international : official journal of the European Society for Organ Transplantation.

ANTI‐INTERLEUKIN 2 RECEPTOR MONOCLONAL ANTIBODY IN THE TREATMENT OF ONGOING ACUTE REJECTION EPISODES OF HUMAN KIDNEY GRAFT‐A PILOT STUDY

M. Giral, J. Soulillou, D. Cantarovich, 1989, Transplantation.

Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. I. Results after combined pancreas and kidney transplantation.

J. Soulillou, J. Dantal, D. Cantarovich, 1994, Transplantation.

Prevention of acute rejection episodes with an anti-interleukin 2 receptor monoclonal antibody. II. Results after a second kidney transplantation.

J. Soulillou, J. Dantal, D. Cantarovich, 1994, Transplantation.

Treatment of acute kidney rejection episodes with monoclonal antibody directed against IL2 receptor: a pilot study.

M. Giral, J. Soulillou, D. Cantarovich, 1989, Transplantation proceedings.